Individualized Bowel Preparation for Colonoscopy
PREP2TARGET
A Randomized Clinical Trial Comparing Standard and Invidualized Bowel Preparation for Colonoscopy
1 other identifier
interventional
450
1 country
2
Brief Summary
A randomized control trial comparing a standard bowel preparation for colonoscopy with an individualized bowel preparation strategy based on patient characteristics
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Feb 2018
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2018
CompletedFirst Submitted
Initial submission to the registry
February 5, 2018
CompletedFirst Posted
Study publicly available on registry
February 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2019
CompletedJanuary 31, 2019
January 1, 2019
1.7 years
February 5, 2018
January 30, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
bowel preparation quality
Boston bowel preparation score (BBPS)
1-2 hours after completing bowel preparation
Secondary Outcomes (1)
patient comfort during bowel preparation
1-2 hours after completing bowel preparation
Study Arms (2)
standard group
ACTIVE COMPARATORstandard polyethylene glycol preparation for colonoscopy
individualized group
EXPERIMENTALeither a low or a high volume bowel preparation according to patient characteristics
Interventions
standard PEG-based bowel preparation for colonoscopy (either split dose 4L polyethylene glycol or split 2L PEG + ascorbic acid)
individualized bowel preparation for colonoscopy (either split dose 4L PEG or split 2L PEG + ascorbic acid) based o patient characteristics (history of failed bowel preparation; use of laxative drugs, increased BMI, age\>65, neurologic comorbidities)
Eligibility Criteria
You may qualify if:
- elective out-patient diagnostic or therapeutic colonoscopy
You may not qualify if:
- pregnant women; refusal to participate; significant comorbidities (ASA score 3 or above); suspicion of bowel perforation;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Colentina Clinical Hospital
Bucharest, 020125, Romania
Carol Davila Emergency Military Hospital
Bucharest, Romania
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Theodor Voiosu
Clinical Hospital Colentina
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- single-blind
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
February 5, 2018
First Posted
February 12, 2018
Study Start
February 1, 2018
Primary Completion
November 1, 2019
Study Completion
November 1, 2019
Last Updated
January 31, 2019
Record last verified: 2019-01